CYTX: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and Cytori Therapeutics Inc (CYTX) is one of the most shorted stocks of the Russell 3000, based on 31.10 "days to cover" versus the median component at 5.87. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

In the case of Cytori Therapeutics Inc ( CYTX), the total short interest at the 08/30/2013 settlement date was 6,720,378 shares, which compares to the average daily trading volume of just 216,071 shares, for a "days to cover" ratio of 31.10.

When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single CYTX share traded represented a short position being closed, then at the average daily volume of 216,071 shares it would only be during the 32nd trading day that every short position would be closed.

So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 32 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.

Cytori Therapeutics Inc ( CYTX) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, CYTX has seen 2 different instances of insider buying, as summarized by the table below:

Purchased Insider Title Shares Price/Share Value
08/30/2013 Tommy G. Thompson Director 5,000 $2.14 $10,700.00
09/04/2013 David Rickey Director 7,000 $2.14 $14,976.00
09/05/2013 David Rickey Director 2,000 $2.24 $4,479.80
09/09/2013 David Rickey Director 5,000 $2.31 $11,549.90
09/11/2013 David Rickey Director 2,000 $2.58 $5,159.90
09/11/2013 David Rickey Director 3,500 $2.57 $8,990.10

Below is a chart showing the "days to cover" for CYTX over time:

Loading+chart++2013+TickerTech.com

And looking at the chart below, CYTX's low point in its 52 week range is $2.09 per share, with $4.93 as the 52 week high point — that compares with a last trade of $2.50.

Cytori Therapeutics Inc Moving Averages Chart

In recent trading, shares of Cytori Therapeutics Inc ( CYTX) were changing hands at $2.50/share.

null

More from Stocks

Markets Look Confused After Latest Beating

Markets Look Confused After Latest Beating

General Electric Expulsion From Dow Symbolizes Unsettled Week in Markets

General Electric Expulsion From Dow Symbolizes Unsettled Week in Markets

How Small-Cap Stocks Can Protect Your Portfolio From a Trade War

How Small-Cap Stocks Can Protect Your Portfolio From a Trade War

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In